INDUSTRIAL SCIENCE & TECHNOLOGY NETWORK, INC.
Novel silicone hydrogel contact lens material with submicron morphology control and advanced fabrication enabling improved tear film compatibility and higher-order aberration correction
- Sector
- Medtech
- Total capital
- $450K
- Federal grants
- $450K
- 2 awards · 2017
- Rank in peer group#20 of 36
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 10 pending · first 2017
- Rank in peer group#7 of 36
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Advances in contact lens materials to extend wear time for a new standard in vision correction and future medical devices$225K
- Federal grantHealth and Human S · Phase I · Advances in contact lens materials to extend wear time for a new standard in vision correction and future medical devices$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianMedtech · Material
- Federal grantsBelow median
- Granted patents#7 · top 19%
- Linked publications#1 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 12- GrantedFacile Clay Exfoliation Using Polymer Silicone SurfactantsUSPTOUS 10,981,830
- GrantedSuperinsulation With NanoporesUSPTOUS 9,567,412
- PendingAdvanced Thermal Insulation by Pore Morphology Control in FoamingUSPTOApplication 14785226
Show all 12 patent records
- Facile Clay Exfoliation Using Polymer Silicone SurfactantsApr 20, 2021 · US 10,981,830Granted
- Superinsulation With NanoporesFeb 14, 2017 · US 9,567,412Granted
- Advanced Thermal Insulation by Pore Morphology Control in FoamingMar 24, 2016 · Application 14785226Pending
- Superinsulation With NanoporesApplication PCTUS2009002693Pending
- Innovative Formulation For Oral Insulin DeliveryApplication PCTUS2008009365Pending
- Nanopore Reactive Adsorbents For The High-efficiency Removal Of Wate SpeciesApplication PCTUS2007023069Pending
- Nanoengineered Composite Defog CoatingApplication PCTUS2007003534Pending
- Immobilized Enzymes And Processes For Preparing And Using SameApplication PCTUS2005042657Pending
- Mucoadhesive Nanocomposite Delivery SystemApplication PCTUS2005017638Pending
- Nanopore Reactive Adsorbents For The High-efficiency Removal Of Waste SpeciesApplication PCTUS2004029450Pending
- Facile Clay Exfoliation Using Polymer Silicone SurfactantsApplication PCTUS2018016712Pending
- Advanced Thermal Insulation By Pore Morphology Control In FoamingApplication PCTUS2014034663Pending
Recent research by its founders
- Effect of Carbon Chain Length, Ionic Strength, and pH on the In Vitro Release Kinetics of Cationic Drugs from Fatty-Acid-Loaded Contact Lenses20216 cites
- Hydrogel-based ocular drug delivery systems for hydrophobic drugs202098 cites
- Evaluation of commercial soft contact lenses for ocular drug delivery: A review202071 cites
Related companies, and why
- FROM THE FUTURE, LLCSimilar federal contract value in Medtech · null in contracts
- Prohibix, LLCSimilar federal contract value in Medtech · null in contracts
- Innovative BioChips LLCSimilar federal contract value in Medtech · null in contracts
- VITALQUAN, LLCSimilar federal contract value in Medtech · null in contracts
- Ropana Vascular Inc.Similar federal contract value in Medtech · null in contracts
- BIODEVEK INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .